Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017
Wilfredo R. Matias
, Yodeline Guillaume, Gertrude Cene Augustin, Kenia Vissieres, Ralph Ternier, Richelle C. Charles, Jason B. Harris, Molly F. Franke, and Louise C. Ivers
Author affiliations: Brigham and Women’s Hospital Division of Infectious Diseases, Boston, Massachusetts, USA (W.R. Matias); Massachusetts General Hospital Center for Global Health, Boston (W.R. Matias, Y. Guillaume); Massachusetts General Hospital Division of Infectious Diseases, Boston (W.R. Matias, R.C. Charles, J.B. Harris, L.C. Ivers); Zanmi Lasante, Croix-des-Bouquets, Haiti (G. Cene Augustin, K. Vissieres, R. Ternier); Harvard Medical School, Boston (R.C. Charles, J.B. Harris, M.F. Franke, L.C. Ivers); Harvard School of Public Health, Boston (R.C. Charles); Harvard Global Health Institute, Cambridge, Massachusetts, USA (L.C. Ivers)
Main Article
Figure
Figure. Serosurvey participants with vibriocidal antibody titers for Ogawa (A) and Inaba (B) Vibrio cholerae serotypes in 2 communities, Centre Department, Haiti, March–August 2017. Samples came from 217 total households, 99 (156 persons) in Cerca-la-Source and 118 (121 persons) in Mirebalais. All participants were adults >18 years of age.
Main Article
Page created: August 01, 2023
Page updated: August 20, 2023
Page reviewed: August 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.